Back to Baker Bros. Advisors LP Baker Bros. Advisors LP

KRYSKRYS

Showing 3 of 25 quarters

Position history for Baker Bros. Advisors LPBaker Bros. Advisors LP's holdings in Krystal Biotech, Inc.

No. Baker Bros. Advisors exited its KRYS (Krystal Biotech) position in Q1 2025. Its Q4 2024 13F listed 169,934 shares worth $26.6M. Baker Bros. Advisors already held KRYS in its Q1 2019 13F, the earliest on record, and held it in 24 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$30.9M

Total Shares Change

-169,934

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$183.92
0
2024-Q4
Unchanged
169,934
0.0%
$26.6M0.3%$159.80
0
2024-Q3
Unchanged
169,934
0.0%
$30.9M0.3%$177.14
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used